Skip to main content
. 2021 Sep 30;9(9):e002569. doi: 10.1136/jitc-2021-002569

Figure 2.

Figure 2

Batf3-dependent CD103+ dendritic cells play an important role in the anti-tumor effects of IT live OV-GM and heat-iOV-GM. (A) Tumor implantation and treatment plan in a unilateral B16-F10 intradermal implantation tumor model. (B) Tumor volumes of injected tumors in WT mice treated with either live OV-GM (n=23), heat-iOV-GM (n=25), or PBS control (n=7), or Batf3-/- mice treated with live OV-GM (n=9) or heat-iOV-GM (n=9) over days post-treatment. (C) Kaplan-Meier survival curve of WT and Batf3-/- mice treated with PBS, live OV-GM, or heat-iOV-GM. (*P < 0.05; ***P < 0.001; ****P < 0.0001). (D) The number of tumor foci on the surface of lungs collected at 3 weeks from either naïve (n=9), or heat-iOV-GM-treated (n=13), or live OV-GM-treated mice (n=14), after intravenous delivery of 1 x 105 B16-F10 cells (*P < 0.05; ****P < 0.0001, t test).